Overlap of Wilson’s disease and non-alcoholic fatty liver disease: is coexistence possible (clinical case and literature review)

Authors

DOI:

https://doi.org/10.22141/2308-2097.55.1.2021.229435

Keywords:

Wilson’s disease, non-alcoholic fatty liver disease, children, review

Abstract

The article presents a literature review and the actual observation of a clinical case of the coexistence of Wilson’s disease and non-alcoholic fatty liver disease in a child. The literature search was performed on databases Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, and others. The article describes the most common causes of persistent elevation of hepatic transaminases in asymptomatic patients and the algorithm of diffe­rential diagnosis in hypertransaminasemia. The spectrum of diseases accompanied by the development of hepatic steatosis is presented, the issues of diagnosis of non-alcoholic liver disease and Wilson’s disease in children are covered. The attention is focused on the difficulties of interpreting clinical data and evaluating the laboratory and instrumental findings in this group of patients. The algorithm of differential diagnosis of non-alcoholic fatty liver disease in children is presented.

Downloads

Download data is not yet available.

References

Mann JP, Gallagher K, Fitzpatrick E, Dhawan A. Fifteen-minute consultation: liver disease in children. Arch Dis Child Educ Pract Ed. 2018 Aug;103(4):170-176. doi:10.1136/archdischild-2017-313036.

Fernández Ventureira V, Ros Arnal I, Rodríguez Martínez G, García Rodríguez B, García Romero R, Ubalde Sainz E. Evaluation of liver function tests in the paediatric patient. An Pediatr (Barc). 2020 Sep 2:S1695-4033(20)30241-1. doi:10.1016/j.anpedi.2020.06.019. (in Spanish).

Keerl C, Bernsmeier C. Elevated liver function tests - as incidental finding in general practice. Ther Umsch. 2020;77(8):371-378. doi:10.1024/0040-5930/a001206. (in German).

Agrawal S, Dhiman RK, Limdi JK. Evaluation of abnormal liver function tests. Postgrad Med J. 2016 Apr;92(1086):223-34. doi:10.1136/postgradmedj-2015-133715.

Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017 Jan;112(1):18-35. doi:10.1038/ajg.2016.517.

Schwimmer JB, Dunn W, Norman GJ, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010 Apr;138(4):1357-64, 1364.e1-2. doi:10.1053/j.gastro.2009.12.052.

England K, Thorne C, Pembrey L, Tovo PA, Newell ML. Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):71-7. doi:10.1097/MPG.0b013e31818fc63b.

Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: a stepwise approach. World J Gastroenterol. 2013 May 14;19(18):2740-51. doi:10.3748/wjg.v19.i18.2740.

Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi:10.1097/MPG.0000000000001482.

Molleston JP, Schwimmer JB, Yates KP, et al; NASH Clinical Research Network. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. J Pediatr. 2014 Apr;164(4):707-713.e3. doi:10.1016/j.jpeds.2013.10.071.

Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med. 2019 Apr;7(Suppl 2):S65. doi:10.21037/atm.2018.12.53.

Gerosa C, Fanni D, Congiu T, et al. Liver pathology in Wilson's disease: From copper overload to cirrhosis. J Inorg Biochem. 2019 Apr;193:106-111. doi:10.1016/j.jinorgbio.2019.01.008.

Socha P, Janczyk W, Dhawan A, et al. Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):334-344. doi:10.1097/MPG.0000000000001787.

Lutsenko S. Modifying factors and phenotypic diversity in Wilson's disease. Ann N Y Acad Sci. 2014 May;1315:56-63. doi:10.1111/nyas.12420.

Fernando M, van Mourik I, Wassmer E, Kelly D. Wilson disease in children and adolescents. Arch Dis Child. 2020 May;105(5):499-505. doi:10.1136/archdischild-2018-315705.

Burkhead JL, Lutsenko S. The Role of Copper as a Modifier of Lipid Metabolism. In: Baez RV, editor. Lipid Metabolism. IntechOpen; 2013. doi:10.5772/51819.

Stepanov YuM, Abaturov АYe, Zavgorodnia NYu, Skyrda IYu. Non-Alcoholic Fatty Liver Disease in Children: Current View on Diagnostics and Treatment (Part I). Gastroenterologіa. 2015;2:99-107. doi:10.22141/2308-2097.2.56.2015.81504. (in Ukrainian).

Aigner E, Strasser M, Haufe H, et al. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010 Sep;105(9):1978-85. doi:10.1038/ajg.2010.170.

Morrell A, Tallino S, Yu L, Burkhead JL. The role of insufficient copper in lipid synthesis and fatty-liver disease. IUBMB Life. 2017 Apr;69(4):263-270. doi:10.1002/iub.1613.

Ee LC. Liver disease in the older child. J Paediatr Child Health. 2020 Nov;56(11):1702-1707. doi:10.1111/jpc.14708.

Published

2021-09-06

How to Cite

Stepanov, Y., Zavhorodnia, N., & Zavhorodnia, O. (2021). Overlap of Wilson’s disease and non-alcoholic fatty liver disease: is coexistence possible (clinical case and literature review). GASTROENTEROLOGY, 55(1), 42–48. https://doi.org/10.22141/2308-2097.55.1.2021.229435

Issue

Section

Reviews and Lections

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>